Your browser doesn't support javascript.
loading
B7H6 Serves as a Negative Prognostic Marker and an Immune Modulator in Human Pancreatic Cancer.
Zhu, Zheng; Teng, Kun-Yu; Zhou, Jian; Xu, Yunyun; Zhang, Lifeng; Zhao, Hua; Zhang, Xueguang; Tian, Lei; Li, Zhiyao; Lu, Ting; Ma, Shoubao; Li, Zhenlong; Dai, Zhenyu; Wang, Jing; Chen, Xingyu; Wu, Xing; Pan, Yihan; Shi, Weiqiang; You, Zhiqun; Chen, Hanyu; Chung, Vincent; Yu, Jianhua; He, Songbing; Zhao, Xin; Cao, Lei; Li, Dechun.
Afiliação
  • Zhu Z; Department of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
  • Teng KY; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, CA, United States.
  • Zhou J; Jiangsu Institute of Clinical Immunology, The First Affiliated Hospital of Soochow University, Suzhou, China.
  • Xu Y; Jiangsu Key Laboratory of Clinical Immunology, Soochow University, Suzhou, China.
  • Zhang L; Jiangsu Key Laboratory of Gastrointestinal Tumor Immunology, The First Affiliated Hospital of Soochow University, Suzhou, China.
  • Zhao H; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, CA, United States.
  • Zhang X; Department of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
  • Tian L; Pediatric Clinical Research Institute, Children's Hospital Affiliated to Soochow University, Suzhou, China.
  • Li Z; Department of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
  • Lu T; Department of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
  • Ma S; Jiangsu Institute of Clinical Immunology, The First Affiliated Hospital of Soochow University, Suzhou, China.
  • Li Z; Jiangsu Key Laboratory of Clinical Immunology, Soochow University, Suzhou, China.
  • Dai Z; Jiangsu Key Laboratory of Gastrointestinal Tumor Immunology, The First Affiliated Hospital of Soochow University, Suzhou, China.
  • Wang J; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, CA, United States.
  • Chen X; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, CA, United States.
  • Wu X; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, CA, United States.
  • Pan Y; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, CA, United States.
  • Shi W; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, CA, United States.
  • You Z; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, CA, United States.
  • Chen H; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, CA, United States.
  • Chung V; Department of General Surgery, Taizhou Fourth People's Hospital, Taizhou, China.
  • Yu J; Department of General Surgery, The First People's Hospital of Huzhou, Huzhou, China.
  • He S; College of Liberal Arts, University of Minnesota Twin Cities, Minneapolis, MN, United States.
  • Zhao X; Department of Pathology, The First Affiliated Hospital of Soochow University, Suzhou, China.
  • Cao L; Department of Pathology, The First Affiliated Hospital of Soochow University, Suzhou, China.
  • Li D; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, CA, United States.
Front Oncol ; 12: 814312, 2022.
Article em En | MEDLINE | ID: mdl-35311080

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China